Abstract
Purpose
The hyperactivation of epidermal growth factor receptor (EGFR) plays a crucial role in non-small cell lung cancer (NSCLC). Hedgehog (Hh) signaling has been implicated in the tumorigenesis and progression of various cancers, however, its function in NSCLC cells remains controversial. Herein, we present a novel finding that challenges the current understanding of Hh signaling in tumor growth.
Methods
Expression of Hh ligands and receptor were assessed using TCGA datasets, immunoblotting and immunohistochemical. Biological function of Hh ligands and receptor in NSCLC were tested using colony formation, cell count kit-8 (CCK-8) and xenograft assays. Biochemical effect of Hh ligands and receptor on regulating EGFR stability and activity were checked via immunoblotting.
Results
Expression of Hh ligands and receptor was suppressed in NSCLC tissues, and the lower expression levels of these genes were associated with poor prognosis. Ptch1 binds to EGFR and facilitates its poly-ubiquitylation and degradation independent of downstream transcriptional signaling. Moreover, Hh ligands cooperate with Ptch1 to regulate the protein stability and activity of EGFR. This unique mechanism leads to a suppressive effect on NSCLC tumor growth.
Conclusion
Non-canonical Hh signaling pathway, involving cooperation between Hh ligands and their receptor Ptch1, facilitates the degradation of EGFR and attenuates its activity in NSCLC. These findings provide novel insights into the regulation of EGFR protein stability and activity, offer new diagnostic indicators for molecular typing of NSCLC and identify potential targets for targeted therapy of this challenging disease.
Similar content being viewed by others
Data availability
Not applicable.
Abbreviations
- BCC:
-
Basal cell carcinoma
- CCK-8:
-
Cell count kit-8
- CHX:
-
Cycloheximide
- Co-IP:
-
Co-immunoprecipitation
- Dhh:
-
Desert Hedgehog
- EGFR:
-
Epidermal growth factor receptor
- EMT:
-
Epithelial-mesenchymal transition
- Her2:
-
Human epidermal growth factor receptor 2
- Hh:
-
Hedgehog
- ICD:
-
Intracellular domain
- IHC:
-
Immunohistochemical
- Ihh:
-
Indian Hedgehog
- NSCLC:
-
Non-small cell lung cancer
- Ptch1:
-
Patched-1
- Shh:
-
Sonic Hedgehog
- TCGA:
-
The Cancer Genome Atlas
- TKIs:
-
Tyrosine kinase inhibitors
References
R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, CA Cancer J. Clin. 72, 7–33 (2022). https://doi.org/10.3322/caac.21708
D.F. Heigener, M. Reck, Nat. Rev. Clin. Oncol. 15, 71–72 (2018). https://doi.org/10.1038/nrclinonc.2017.178
R.S. Herbst, J.V. Heymach, S.M. Lippman, N Engl. J. Med. 359, 1367–1380 (2008). https://doi.org/10.1056/NEJMra0802714
R. Jr. Roskoski, Pharmacol. Res. 87, 42–59 (2014). https://doi.org/10.1016/j.phrs.2014.06.001
R.T. Lee, Z. Zhao, P.W. Ingham, Development. 143, 367–372 (2016). https://doi.org/10.1242/dev.120154
T.K. Rimkus, R.L. Carpenter, S. Qasem, M. Chan, H.W. Lo, Cancers (Basel). 8 (2016). https://doi.org/10.3390/cancers8020022
J.E. Cortes, R. Gutzmer, M.W. Kieran, J.A. Solomon, Cancer Treat. Rev. 76, 41–50 (2019). https://doi.org/10.1016/j.ctrv.2019.04.005
J. Briscoe, P.P. Therond, Nat. Rev. Mol. Cell. Biol. 14, 416–429 (2013). https://doi.org/10.1038/nrm3598
N. Takebe, L. Miele, P.J. Harris, W. Jeong, H. Bando, M. Kahn, S.X. Yang, S.P. Ivy, Nat. Rev. Clin. Oncol. 12, 445–464 (2015). https://doi.org/10.1038/nrclinonc.2015.61
D. Huang, Y. Wang, L. Xu, L. Chen, M. Cheng, W. Shi, H. Xiong, D. Zalli, S. Luo, J. Exp. Clin. Cancer Res. 37, 247 (2018). https://doi.org/10.1186/s13046-018-0917-x
S. Zeng, F. Zhou, Y. Wang, Z. Zhai, L. Xu, H. Wang, X. Chen, S. Luo, M. Cheng, Acta Biochim. Biophys. Sin (Shanghai). 54, 243–251 (2022). https://doi.org/10.3724/abbs.2021018
Z. Yan, M. Cheng, G. Hu, Y. Wang, S. Zeng, A. Huang, L. Xu, Y. Liu, C. Shi, L. Deng, Q. Lu, H. Rao, H. Lu, Y.G. Chen, S. Luo, Cell. Death Dis. 12, 199 (2021). https://doi.org/10.1038/s41419-021-03487-0
G. Hu, Z. Yan, C. Zhang, M. Cheng, Y. Yan, Y. Wang, L. Deng, Q. Lu, S. Luo, J. Exp. Clin. Cancer Res. 38, 188 (2019). https://doi.org/10.1186/s13046-019-1202-3
J.W. Theunissen, F.J. de Sauvage, Cancer Res. 69, 6007–6010 (2009). https://doi.org/10.1158/0008-5472.CAN-09-0756
S. Kasiri, B. Chen, A.N. Wilson, A. Reczek, S. Mazambani, J. Gadhvi, E. Noel, U. Marriam, B. Mino, W. Lu, L. Girard, L.M. Solis, K. Luby-Phelps, J. Bishop, J.W. Kim, J. Kim, Oncogene. 39, 3258–3275 (2020). https://doi.org/10.1038/s41388-020-1224-5
J.J. Lee, R.M. Perera, H. Wang, D.C. Wu, X.S. Liu, S. Han, J. Fitamant, P.D. Jones, K.S. Ghanta, S. Kawano, J.M. Nagle, V. Deshpande, Y. Boucher, T. Kato, J.K. Chen, J.K. Willmann, N. Bardeesy, P.A. Beachy, Proc. Natl. Acad. Sci. U. S. A. 111, E3091-3100 (2014) https://doi.org/10.1073/pnas.1411679111
A.D. Rhim, P.E. Oberstein, D.H. Thomas, E.T. Mirek, C.F. Palermo, S.A. Sastra, E.N. Dekleva, T. Saunders, C.P. Becerra, I.W. Tattersall, C.B. Westphalen, J. Kitajewski, M.G. Fernandez-Barrena, M.E. Fernandez-Zapico, C. Iacobuzio-Donahue, K.P. Olive, B.Z. Stanger, Cancer Cell. 25, 735–747 (2014). https://doi.org/10.1016/j.ccr.2014.04.021
K. Shin, A. Lim, J.I. Odegaard, J.D. Honeycutt, S. Kawano, M.H. Hsieh, P.A. Beachy, Nat. Cell. Biol. 16, 469–478 (2014). https://doi.org/10.1038/ncb2956
K. Shin, A. Lim, C. Zhao, D. Sahoo, Y. Pan, E. Spiekerkoetter, J.C. Liao, P.A. Beachy, Cancer Cell. 26, 521–533 (2014). https://doi.org/10.1016/j.ccell.2014.09.001
M. Gerling, N.V. Buller, L.M. Kirn, S. Joost, O. Frings, B. Englert, A. Bergstrom, R.V. Kuiper, L. Blaas, M.C. Wielenga, S. Almer, A.A. Kuhl, E. Fredlund, G.R. van den Brink, R. Toftgard, Nat. Commun. 7, 12321 (2016). https://doi.org/10.1038/ncomms12321
Z. Yang, Y.C. Peng, A. Gopalan, D. Gao, Y. Chen, A.L. Joyner, Dis. Model. Mech. 10, 39–52 (2017). https://doi.org/10.1242/dmm.027417
R. Oughtred, J. Rust, C. Chang, B.J. Breitkreutz, C. Stark, A. Willems, L. Boucher, G. Leung, N. Kolas, F. Zhang, S. Dolma, J. Coulombe-Huntington, A. Chatr-Aryamontri, K. Dolinski, M. Tyers, Protein Sci. 30, 187–200 (2021). https://doi.org/10.1002/pro.3978
J.M. Bowen, I. White, L. Smith, A. Tsykin, K. Kristaly, S.K. Thompson, C.S. Karapetis, H. Tan, P.A. Game, T. Irvine, D.J. Hussey, D.I. Watson, D.M. Keefe, Support Care Cancer. 23, 3165–3172 (2015). https://doi.org/10.1007/s00520-015-2696-7
E.L. Huttlin, R.J. Bruckner, J. Navarrete-Perea, J.R. Cannon, K. Baltier, F. Gebreab, M.P. Gygi, A. Thornock, G. Zarraga, S. Tam, J. Szpyt, B.M. Gassaway, A. Panov, H. Parzen, S. Fu, A. Golbazi, E. Maenpaa, K. Stricker, S. Guha Thakurta, T. Zhang, R. Rad, J. Pan, D.P. Nusinow, J.A. Paulo, D.K. Schweppe, L.P. Vaites, J.W. Harper, S.P. Gygi, Cell. 184, 3022–3040e3028 (2021). https://doi.org/10.1016/j.cell.2021.04.011
E.L. Huttlin, L. Ting, R.J. Bruckner, F. Gebreab, M.P. Gygi, J. Szpyt, S. Tam, G. Zarraga, G. Colby, K. Baltier, R. Dong, V. Guarani, L.P. Vaites, A. Ordureau, R. Rad, B.K. Erickson, M. Wühr, J. Chick, B. Zhai, D. Kolippakkam, J. Mintseris, R.A. Obar, T. Harris, S. Artavanis-Tsakonas, M.E. Sowa, P. De Camilli, J.A. Paulo, J.W. Harper, S.P. Gygi, Cell. 162, 425–440 (2015). https://doi.org/10.1016/j.cell.2015.06.043
M. Cheng, H. Xue, W. Cao, W. Li, H. Chen, B. Liu, B. Ma, X. Yan, Y.G. Chen, J. Biol. Chem. 291, 12871–12879 (2016). https://doi.org/10.1074/jbc.M115.708818
H. Hahn, C. Wicking, P.G. Zaphiropoulous, M.R. Gailani, S. Shanley, A. Chidambaram, I. Vorechovsky, E. Holmberg, A.B. Unden, S. Gillies, K. Negus, I. Smyth, C. Pressman, D.J. Leffell, B. Gerrard, A.M. Goldstein, M. Dean, R. Toftgard, G. Chenevix-Trench, B. Wainwright, A.E. Bale, Cell. 85, 841–851 (1996)
R.L. Johnson, A.L. Rothman, J. Xie, L.V. Goodrich, J.W. Bare, J.M. Bonifas, A.G. Quinn, R.M. Myers, D.R. Cox, E.H. Jr. Epstein, M.P. Scott, Science. 272, 1668–1671 (1996)
C. Raffel, R.B. Jenkins, L. Frederick, D. Hebrink, B. Alderete, D.W. Fults, C.D. James, Cancer Res. 57, 842–845 (1997)
M.D. Taylor, L. Liu, C. Raffel, C.C. Hui, T.G. Mainprize, X. Zhang, R. Agatep, S. Chiappa, L. Gao, A. Lowrance, A. Hao, A.M. Goldstein, T. Stavrou, S.W. Scherer, W.T. Dura, B. Wainwright, J.A. Squire, J.T. Rutka, D. Hogg, Nat. Genet. 31, 306–310 (2002). https://doi.org/10.1038/ng916
U. Tostar, C.J. Malm, J.M. Meis-Kindblom, L.G. Kindblom, R. Toftgard, A.B. Unden, J. Pathol. 208, 17–25 (2006). https://doi.org/10.1002/path.1882
D.N. Watkins, D.M. Berman, S.G. Burkholder, B. Wang, P.A. Beachy, S.B. Baylin, Nature. 422, 313–317 (2003). https://doi.org/10.1038/nature01493
M. Kubo, M. Nakamura, A. Tasaki, N. Yamanaka, H. Nakashima, M. Nomura, S. Kuroki, M. Katano, Cancer Res. 64, 6071–6074 (2004). https://doi.org/10.1158/0008-5472.CAN-04-0416
D. Qualtrough, A. Buda, W. Gaffield, A.C. Williams, C. Paraskeva, Int. J. Cancer. 110, 831–837 (2004). https://doi.org/10.1002/ijc.20227
M. Monzo, I. Moreno, R. Artells, R. Ibeas, A. Navarro, J. Moreno, R. Hernandez, M. Granell, J. Pie, Cancer Lett. 233, 117–123 (2006). https://doi.org/10.1016/j.canlet.2005.03.001
A. Po, M. Silvano, E. Miele, C. Capalbo, A. Eramo, V. Salvati, M. Todaro, Z.M. Besharat, G. Catanzaro, D. Cucchi, S. Coni, L. Di Marcotullio, G. Canettieri, A. Vacca, G. Stassi, E. De Smaele, M. Tartaglia, I. Screpanti, R. De Maria, E. Ferretti, Oncogene. 36, 4641–4652 (2017). https://doi.org/10.1038/onc.2017.91
D. Carpenter, D.M. Stone, J. Brush, A. Ryan, M. Armanini, G. Frantz, A. Rosenthal, F.J. de Sauvage, Proc. Natl. Acad. Sci. U S A 95, 13630–13634 (1998). https://doi.org/10.1073/pnas.95.23.13630
M. Kasper, H. Schnidar, G.W. Neill, M. Hanneder, S. Klingler, L. Blaas, C. Schmid, C. Hauser-Kronberger, G. Regl, M.P. Philpott, F. Aberger, Mol. Cell. Biol. 26, 6283–6298 (2006). https://doi.org/10.1128/MCB.02317-05
H. Schnidar, M. Eberl, S. Klingler, D. Mangelberger, M. Kasper, C. Hauser-Kronberger, G. Regl, R. Kroismayr, R. Moriggl, M. Sibilia, F. Aberger, Cancer Res. 69, 1284–1292 (2009). https://doi.org/10.1158/0008-5472.CAN-08-2331
M. Eberl, S. Klingler, D. Mangelberger, A. Loipetzberger, H. Damhofer, K. Zoidl, H. Schnidar, H. Hache, H.C. Bauer, F. Solca, C. Hauser-Kronberger, A.N. Ermilov, M.E. Verhaegen, C.K. Bichakjian, A.A. Dlugosz, W. Nietfeld, M. Sibilia, H. Lehrach, C. Wierling, F. Aberger, EMBO Mol. Med. 4, 218–233 (2012). https://doi.org/10.1002/emmm.201100201
F. Gotschel, D. Berg, W. Gruber, C. Bender, M. Eberl, M. Friedel, J. Sonntag, E. Rungeler, H. Hache, C. Wierling, W. Nietfeld, H. Lehrach, A. Frischauf, R. Schwartz-Albiez, F. Aberger, U. Korf, PLoS One. 8 (2013). https://doi.org/10.1371/journal.pone.0065403. e65403
G. Zhu, J. Zhou, W. Song, D. Wu, Q. Dang, L. Zhang, L. Li, X. Wang, D. He, Oncol. Rep. 30, 904–910 (2013). https://doi.org/10.3892/or.2013.2534
M. Benvenuto, L. Masuelli, E. De Smaele, M. Fantini, R. Mattera, D. Cucchi, E. Bonanno, E. Di Stefano, G.V. Frajese, A. Orlandi, I. Screpanti, A. Gulino, A. Modesti, R. Bei, Oncotarget. 7, 9250–9270 (2016). https://doi.org/10.18632/oncotarget.7062
W.G. Hu, T. Liu, J.X. Xiong, C.Y. Wang, Acta Pharmacol. Sin. 28, 1224–1230 (2007). https://doi.org/10.1111/j.1745-7254.2007.00620.x
S. Eimer, F. Dugay, K. Airiau, T. Avril, V. Quillien, M.A. Belaud-Rotureau, F. Belloc, Neuro Oncol. 14, 1441–1451 (2012). https://doi.org/10.1093/neuonc/nos266
G. Shaw, D.M. Prowse, Cancer Cell. Int. 8, 3 (2008). https://doi.org/10.1186/1475-2867-8-3
A. Ahmad, M.Y. Maitah, K.R. Ginnebaugh, Y. Li, B. Bao, S.M. Gadgeel, F.H. Sarkar, J. Hematol. Oncol. 6, 77 (2013). https://doi.org/10.1186/1756-8722-6-77
J.E. Kim, H. Kim, J.Y. Choe, P. Sun, S. Jheon, J.H. Chung, Ann. Surg. Oncol. 20(Suppl 3), 570–576 (2013). https://doi.org/10.1245/s10434-013-3022-6
Funding
This work was supported in part by the grants from the National Natural Science Foundation of China (No. 32260160 to M.C., No. 82160507 to H.W. and 32070783 to S.L.), and the Natural Science Foundation of Jiangxi Province (No. 20212ACB206009 to M.C., 20202BBG72003 to S.L., and 20232ACB206034 to H.W.).
Author information
Authors and Affiliations
Contributions
M.C. and S.L. designed all the experiments; A.H., J.C., M.C., and H.W. conducted the function assays in cell lines and nude mice; Y.Z., Y.W., Q.C., and X.X. conducted the IHC staining and clinical investigations; A.H., J.C., Y.X. and F.Z. handled all the biochemical analysis; M.C. and S.L. analyzed and organized the data; A.H., M.C. and S.L. wrote the manuscript; and all the authors revised the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
All experiments with human tissue samples were approved and supervised by the Ethics Committee of the First Affiliated Hospital of Nanchang University ([2022]CDYFYYLK[06–023]). Protocols for animal experiments were approved by the Ethical Committee of the First Affiliated Hospital of Nanchang University and conformed to the guidelines of the National Institutes of Health on the Ethical Use of Animals.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Material 1
: Supplementary Fig. 1. Supplementary to Fig. 1. A. Immunohistochemical assays confirmed that the protein levels of EGFR and p-EGFR were higher in lung adenocarcinoma tissues than in normal lung tissue. n = 5, Scale bars, 100 μm (above), 50 μm (below)
Supplementary Material 2
: Supplementary Fig. 2. Supplementary to Fig. 4. A. Construction of an overexpression Ptch1 cell line in PC-9 cells. B. Ptch1 decreases the protein level of EGFR in PC-9 cells. C. Representative images showing IHC staining of both human control and Ptch1 tissues in the section stained for EGFR, Ptch1 and Ki67 detection. Scale bars, 100 μm (200x), 50 μm (400x)
Supplementary Material 3
: Supplementary Fig. 3. Supplementary to Fig. 6. A. Ptch1 regulates EGFR independent of the transcriptional activity of targets downstream of the canonical Hh signaling. HEK-293T cells were transfected with Flag-Ptch1 and cultured for 48 h. They were then pretreated with N-Shh conditional medium with or without the Gli inhibitor GANT61 before harvesting. The lysates were examined via IB with the indicated antibodies. B. mRNA levels of Hh target genes in PC-9 cells with or without stable Ptch1 expression and treated with GFP or N-Shh was determined by qPCR. C-D. HEK-293T cells transfected with Flag-Ptch1 were treated with N-Shh conditional medium in a time gradient, and Hh ligand stimulation was shown to induce Ptch1-mediated EGFR degradation. E. In A549 cells, the expression of Ptch1 did not affect the protein level of EGFR. F-G. A549 cells stably expressing Lv-Ptch1 were treated with N-Shh conditional medium in a time gradient, and Hh ligand stimulation was shown to promote EGFR degradation after Ptch1 is expressed. H-I. Time-gradient EGF stimulation activates EGFR phosphorylation, and the effect of the Hh ligands and receptor Ptch1 on EGFR phosphorylation was measured. Hh ligands synergize with Ptch1 to inhibit EGFR activity. The data are presented as the mean ± SD (n = 3), ***p < 0.001, n.s., not significance. J. Immunofluorescence for co-localization of EGFR with EEA1 in overexpressing Ptch1 and control cells treated with GFP or N-shh conditioned medium. Scale bars, 10 μm. K. There was no significant effect on the co-localization of EGFR and EEA1 in overexpressing Ptch1 and control cells treated with GFP or N-shh conditioned medium, The data are presented as the mean ± SD (n = 3), ***p < 0.001, n.s., not significance
Supplementary Material 4
: Supplementary table 1 Primers
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, A., Cheng, J., Zhan, Y. et al. Hedgehog ligand and receptor cooperatively regulate EGFR stability and activity in non-small cell lung cancer. Cell Oncol. (2024). https://doi.org/10.1007/s13402-024-00938-6
Accepted:
Published:
DOI: https://doi.org/10.1007/s13402-024-00938-6